Philippe Sauvage - 07 Oct 2024 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
Chief Financial Officer
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
NUVB
Transactions as of
07 Oct 2024
Net transactions value
$0
Form type
4
Filing time
09 Oct 2024, 16:09:53 UTC
Next filing
04 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Award $0 +750,000 $0.000000 750,000 07 Oct 2024 Class A Common Stock 750,000 $2.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests as to 25% on the one year anniversary of 10/7/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.